A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 98
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : TT
Long Form : triple therapy
No. Year Title Co-occurring Abbreviation
2020 Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence. DT, OAT, PCI
2020 Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients. ST
2020 Open triple therapy for chronic obstructive pulmonary disease: Patterns of prescription, exacerbations and healthcare costs from a large Italian claims database. COPD, NHS
2019 Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. AF, DAPT, DT, OAC, PCI, ST
2019 Comparative Effectiveness and Safety of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome or Percutaneous Coronary Intervention. ACS, AF, DT, MACCEs, PCIs
2019 Comparative effectiveness of triple therapy versus dual bronchodilation in COPD. BECs, DB, HR, ICSs, LABAs, LAMAs, OCS
2019 Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating 'target trials' (the ADAPTT Study). ACS, CABG, CPRD, DAPT, HES, PCI
2019 Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease. COPD
2019 Effects of addition of probiotic and/or bismuth to triple therapy of H. pylori and analysis of genetic variation of 23S rRNA gene between patients with clarithromycin sensitivity and resistance. PCR
10  2019 Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials. ART, DT, PLWHA, RCTs
11  2019 Examining the Risks of Major Bleeding Events in Older People Using Antithrombotics. aRR, DAPT, GI-bleeding
12  2019 Ischemic and bleeding outcomes of triple therapy in patients on chronic anticoagulation undergoing percutaneous coronary intervention: A meta-analysis of randomized trials. CI, DT, MI, OR, PCI, RCTs, ST
13  2019 Safe and Efficacious Use of 1-Month Triple Therapy in Patients with Atrial Fibrillation and High Bleeding Risk Undergoing PCI. AF, PCI
14  2019 Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea. CT, ITT, PP, ST
15  2019 Ten-day concomitant, 10-day sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection: a randomized nationwide trial in Korea. CT, ITT, PP, ST
16  2019 Trial Sequential Analysis Comparing Bleeding and Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation and Acute Coronary Syndrome on Dual versus Triple Therapy. ACS, AF, DT, MACE, PCI, RCTs, TSA
17  2018 Antithromboembolic Strategies for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. AF, DT, PCI
18  2018 Antithrombotic Regimens in Patients With Percutaneous Coronary Intervention Whom an Anticoagulant Is Indicated: A Systematic Review and Network Meta-Analysis. DOAC, DT, PCI, VKA
19  2018 Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Where Are We Now? AF, CV, DT, PCI
20  2018 Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study. ITT, PP, ST
21  2018 Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis. AF, CI, DAPT, MACE, MI, OR
22  2018 Impact of Antithrombotic Regimen on Mortality, Ischemic, and Bleeding Outcomes after Transcatheter Aortic Valve Replacement. AP, CI, HRs, MI, SAC, TAVR
23  2018 Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting. COPD, ED
24  2018 Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717. DT
25  2018 Influence of the inflammatory response on treatment of hepatitis C with triple therapy. HCV, IFN, IL, RANTES, RBV, SVR
26  2018 Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes Without Atrial Fibrillation? ACS, DAPT, MACE, NOACs
27  2018 Triple antithrombotic therapy in patients with atrial fibrillation undergoing PCI: current evidence and practice. ---
28  2018 Triple therapy at discharge from internal medicine wards in heart failure patients with reduced ejection fraction: results from an observational study. ---
29  2017 Combinatorial therapy with two pro-coagulants and one osmotic agent reduces the extent of the lesion in the acute phase of spinal cord injury in the rat. SCI
30  2017 Dual versus single antiplatelet therapy for patients with long-term oral anticoagulation undergoing coronary intervention: a systematic review and meta-analysis. CI, MACCE, OAC, OR, OR, OR, PE, TIA
31  2017 Safety and efficacy of anti-thrombotic regimens in patients with percutaneous coronary intervention requiring oral anticoagulation: A traditional and network meta-analysis. CENTRAL, CI, CrI, CV, DAPT, MACE, MI, OAC, OR, PCI, PRISMA, TVR
32  2017 Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes. CI, DT, LDFP, MD, MT
33  2017 Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review. ACS, AF, DAPT, OAC
34  2016 Clinical Relevance of Anticoagulation and Dual Antiplatelet Therapy to the Outcomes of Patients With Atrial Fibrillation and Recent Percutaneous Coronary Intervention With Stent. AF, DAPT, DT, OAC
35  2016 Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification. AF, DAPT, MACE, PCI
36  2016 High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting. AF, DAPT, HPR, r-ADP-agg
37  2016 Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. AF, DAPT, PCI
38  2016 Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract. HIV-1
39  2016 Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial. ST
40  2016 Short- and long-term efficacy and safety of triple vs. dual antithrombotic therapy in patients with drug-eluting stent implantation and an indication for oral anticoagulation: a meta-analysis. DES, DT, MACCE, MB, OACs
41  2016 Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective study. CT, ST
42  2015 Antithrombotic therapy after percutaneous coronary intervention in patients requiring oral anticoagulant treatment. A meta-analysis. DAPT, DT, MACE, OAC
43  2015 Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry). AF, CI, DAPT, PCI
44  2015 Bridging therapy with low molecular weight heparin in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: the AFCAS study. AF, BARC, LMWH, PCI, VKA-TT
45  2015 Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention. CI, DAPT, DT, MACE, MI, OACs, OR
46  2015 New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. DAPT, NOACs, OAC, PCI-S
47  2015 Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors. DT, eGFR, Hb, RI, SCr
48  2015 Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis. CIs, CT, ITT, OR, OR, PP, ST
49  2015 Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection. CT, ITT, mITT, PP, ST
50  2015 The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. GOLD, ICS, LABA
51  2015 [Incidence, management and costs of adverse effects in chronic hepatitis C patients on triple therapy with telaprevir or boceprevir: first 12 weeks of treatment]. AE, BOC, TVR
52  2014 Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapy. Cho, CNS, mI, MRI, MT, MT, NAA, NI, PI
53  2014 Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study. DT
54  2014 CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study. DT, GDS, NP
55  2014 Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C. BOC, CHC, ICER, LYG, QALY, SOF, TVR
56  2014 Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review. ACS, DAPT
57  2014 One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. AF, AFCAS, MACCE, PCI-S, VKA
58  2014 Outcome of patients on oral anticoagulation undergoing coronary artery stenting: data from discharge to 12 months in the Warfarin and Coronary Stenting (WAR-STENT) Registry. DAPT, DT, MACE, OAC, PCI-S, WAR-STENT
59  2014 Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. CPA, HVPG, MT
60  2014 Sequential therapy or triple therapy for Helicobacter pylori infection in Asians: systematic review and meta-analysis. ITT, OR, PP, ST
61  2014 The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview. NOAC, OAC, PCI-S, VKA
62  2013 Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation. AF, DAPT, PCI
63  2013 Balancing between bleeding and thromboembolism after percutaneous coronary intervention in patients with atrial fibrillation. Could triple anticoagulant therapy be a solution? AF, DT, PCI, VKA
64  2013 Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR Trial. DAS-ESR, LDA, MTX, RA, TEAR
65  2013 Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C. BOC, CHC, DT, ICER, LYG, NR, PAR, QALY, RCTs, TVR
66  2013 Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial. AF, DAPT, OAC, PCI-S
67  2013 How to optimize HCV therapy in genotype 1 patients: predictors of response. BOC, CHC, DT, eRVR, RVR, SVR, TVR
68  2013 In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry. CI, MACE, OR, PCI-S, WAR-STENT
69  2013 Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis. CI, ITT, ORs, PP, ST
70  2013 Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: impact of different photodynamic therapy parameters. BCVA, PDT
71  2012 Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. VKA
72  2012 Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C. BOC, BOC-IL28B, BOC-RGT, CHC, DT, ICER, LYG, RCTs, RVR, TVR, TVR-IL28B, TVR-RGT
73  2012 Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy. H. pylori, LF, PB, ST
74  2012 The antithrombotic management of patients on oral anticoagulation undergoing coronary stent implantation: an update. OAC
75  2012 Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? BOC, CHC, SVR, TVR
76  2011 Coronary stent implantation in patients committed to long-term oral anticoagulation therapy: successfully navigating the treatment options. OAC
77  2011 Curcumin alleviates matrix metalloproteinase-3 and -9 activities during eradication of Helicobacter pylori infection in cultured cells and mice. cag, HP
78  2011 Helicobacter pylori infection: is sequential therapy superior to standard triple therapy? A single-centre Italian study in treatment-naive and non-treatment-naive patients. ST
79  2011 Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation. CIs, DT, PCI, RRs
80  2011 Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation. ASA, INR, OAC
81  2011 The risk of bleeding of triple therapy with vitamin K-antagonists, aspirin and clopidogrel after coronary stent implantation: Facts and questions. PCI-S, VKA
82  2010 Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting. OAC, PCI
83  2010 Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. H. pylori, NS, OM
84  2010 Novel combination therapy for the eradication of Helicobacter pylori infection in a mouse model. ---
85  2009 Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome. ACEIs, AIIRAs, DT, QT
86  2009 Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. CI, NNT, OR, RCTs, ST
87  2009 Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study. AC, DAT, OAT, PCI-S
88  2007 Antiretroviral agents and acid-base balance at delivery of the neonate. ARV
89  2006 Antiretroviral agents during pregnancy: consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. ---
90  2006 Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. HCV, MT
91  2006 Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II. Ang II, CTGF, SHR
92  2005 Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates. ---
93  2005 Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system. SHR, WKY
94  2001 Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate. ELISA, IFN-alpha, IL-6, NRs, SRs, TGF-beta, TNF-alpha
95  2000 Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. PPI, QT
96  1997 Perindopril ameliorates glomerular and renal tubulointerstitial injury in the SHR/N-corpulent rat. cp, PE, SBP
97  1994 Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. CBS
98  1988 Current experience with renal transplantation in older patients. AP, Cad, LRD